Company Update1 Min Read InvestyWise NewsonApril 7, 2026 Oberoi Realty NCLT Approves Amalgamation of Nirmal Lifestyle Realty Oberoi Realty has received formal approval from the National Company Law Tribunal (NCLT) for the amalgamation of Nirmal Lifestyle Realty…
Other Announcements1 Min Read InvestyWise NewsonApril 7, 2026 Indian Overseas Bank Half-Yearly Statement of Debt Securities Released Indian Overseas Bank has published its statement of debt securities for the half-year ending March 31, 2026. The report details the…
Company Update2 Min Read InvestyWise NewsonApril 7, 2026 CIE Automotive India Dividend Declaration and Tax Deduction Guidelines CIE Automotive India Limited has announced a recommended dividend of Rs. 7 per equity share for the financial year ended December 31, 2025.…
Company Update1 Min Read InvestyWise NewsonApril 7, 2026 Indian Overseas Bank Annual Disclosure of Non-Convertible Securities for FY 2025-26 Indian Overseas Bank has released its annual disclosure regarding non-convertible securities for the financial year 2025-26. The report…
Company Update1 Min Read InvestyWise NewsonApril 7, 2026 Manappuram Finance Update on Open Offer Share Tendering Manappuram Finance Limited has provided an update regarding the ongoing open offer process for its equity shares. As of April 7, 2026, no…
Company Update1 Min Read InvestyWise NewsonApril 7, 2026 International Gemological Institute Limited Corporate Name Change Official International Gemological Institute Limited has formally announced a change to its corporate name. Effective April 7, 2026, the entity…
Board Meeting1 Min Read InvestyWise NewsonApril 7, 2026 Life Insurance Corporation of India Board to Consider Bonus Share Issue Life Insurance Corporation of India (LIC) has announced that its Board of Directors will meet on April 13, 2026. The primary agenda for the…
Company Update1 Min Read InvestyWise NewsonApril 7, 2026 Aurobindo Pharma Receives USFDA Approval for Diabetes Medication Aurobindo Pharma has received final approval from the USFDA to manufacture and market Dapagliflozin and Metformin Hydrochloride…
Company Update1 Min Read InvestyWise NewsonApril 7, 2026 Aurobindo Pharma Receives USFDA Approval for Dapagliflozin Tablets Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dapagliflozin…
Company Update1 Min Read InvestyWise NewsonApril 7, 2026 Orchid Pharma Whole Time Director to Participate in Investor Roadshow Orchid Pharma has announced that Mr. Mridul Dhanuka, Whole Time Director, will represent the company at an upcoming investor engagement. The…